These results suggest that the delay of T-ALL progression observed in N3tg/p50−/− vs. N3tg mice at 8–9 weeks of age (see Figure 2), is already effective at an initial stage of the disease. Here, NFKB1 is linked to acute lymphoblastic leukemia.